An in-depth look to G&E HERBAL BIOTECHNOLOGY CO. LTD. operating, investing, and financing activities

4911 free cash flow for Q3 24 is -941 k TWD. For 2023, 4911 free cash flow was 110.9 M TWD and operating cash flow was 116.42 M TWD.